The aggressiveness of a tumour, or individual clones of cells within a tumour, might be reflected by expression or deletion of certain cell products involved in e.g. cell growth regulation, cell to cell interactions and cell differentiation (Hakomori, 1980; Weinstein et al., 1981) . Deletion of ABH blood group isoantigens has prognostic implications in carcinoma of the urinary bladder (Limas et al., 1979; Weinstein et al., 1981) . The prognostic relevance of blood group substances (BGS) in colorectal carcinoma is unknown, although a prognostic value has been indicated (Wiley et al., 1981) . It has, however, been convincingly demonstrated that BGS A, BGS B, BGS H and Lewis B antigens are oncofoetal products of the normal distal colon and rectum, (Arends et al., 1984a; Atkinson et al., 1982; Cooper & Haessler, 1978; Denk et al., 1974a Denk et al., , b., 1975 Ernst et al., 1984; Szulman, 1962; Szulman & Marcus, 1973) . Several other antigens like carcinoembryonic antigen (CEA), gastrointestinal cancer antigen (GICA), carcinoma-associated antigen (CA-50), and difucosylated carbohydrate antigen (DFCA) have also been demonstrated in association with colorectal cancer in a high proportion of cases (Arends et al., 1984a; Atkinson et al., 1982; Enblad et al., 1986; Lindholm et al., 1983; Nilsson et al., 1985) . The pattern of CEA expression has recently been reported to correlate with patient survival (Wiggers et al., 1986) , and a possible prognostic value of GICA immunoreactivity has also been indicated (Arends et al., 1984a) .
The present immunohistochemical study concerns the expression of BGS and the tumour associated antigens mentioned above in carcinoma of the rectum and rectosigmoid. The ultimate aim was to assess the prognostic significance of the expression patterns of these antigens, both in preoperative diagnostic biopsies and in postoperative samples. In the fundamental parts of the study presented here, the objectives were to: (a) assess the extent of intratumoral antigenic heterogeneity; (b) determine the degree of individuality, i.e. intertumoral heterogeneity; (c) (1/200 v/v; 30min) . Staining was developed in 3-amino-9-etyl-carbazole and 0.002% hydrgen peroxide (15min), and counterstained in Mayers' haematoxylin (5min). Primary antibody was regularly substituted on parallel sections by 1% bovine serum albumin in order to exclude non-specific staining. The sensitivity was ascertained by repeated stainings of positive and negative tumour specimens.
Evaluation
All staining results were evaluated independently by 3 of the authors (P.E., B.G. and C.B.). The proportion of the total sectioned tumour area positively stained (0%/ <10%/1-50%/50-90%/>90%) was estimated. The staining intensity was not judged since preliminary results showed that virtually all positive cases were strongly stained. In order to (quantify' intratumoral variability and to assess the accuracy of a classification based on preoperative biopsies the stained sections were divided into areas corresponding to the size of fictive biopsies, i.e. that could have been taken through a rigid sigmoidoscope (determined to be 12mm2, mean; range 4-24, from 30 randomly selected biopsies). Practically, the fictive biopsy areas were scored using an eyepiece with outlined square markings. In the tumours sampled at multiple sites the staining patterns of each part were compared as was the staining of lymph node and liver secondaries, respectively, with that of the primary tumour. The ABO blood type was ascertained from the reactions in endothelium and erythrocytes. Secretor status (Lewis phenotype) was not assessed.
Results
The staining method was reliable, and classification of reactions, scored independently by three observers, was consistent in the majority of cases.
Each antibody had its own characteristic expression. Besides differences in regional distribution of the antigens, differences in cellular localisation were also noted. Cytoplasmic staining dominated for BGS A, BGS B, BGS H, DFCA, Le B and CA-50; membranous and intraluminal for CEA and GICA. The estimated proportions of cells positive for the different antigens are presented in Table  IIA-G. Table IIA Figure 1 ). The heterogeneity was equally prominent in peripheral and central areas of the tumours. A similar heterogeneity was also seen in the snapfrozen sections (data not illustrated).
The proportions of positive cells in the fictive preoperative biopsies varied considerably; for several of the antibodies from 0-100% within the same section. The overall proportion of positve cells did not, however, vary much between the larger samples (sections of approximate size 10 x 1Omm) taken from different regions of the surgical specimens (Table III, Figure 1 ).
Intertumoral antigenic heterogeneity or individuality A considerable divergency in antigenic expression was seen between the tumours. The proportion of positive cells, according to the defined categories, varied between 0%->90% for all antigens, except for CEA (Table II) . If all antigens were accounted for in an immunohistochemical profile 64 different phenotypes were recognized from the defined proportions of positive cells. If the classification was restricted to 'negative' (0% and < 10%), 'heterogeneous' (10-50% and 50-90%) and 'positive' (>90%), 56 different phenotypes were seen. The cases without a phenotype of their own were not clustered to one or a few phenotypes.
Antigenic heterogeneity in metastases There was no consistent staining pattern in the lymph node metastases and liver secondaries, suggestive of a phenotype with high metastatic potential. Heterogeneous staining patterns occurred within the metastases, regardless of the antigenic state on the primary tumour (heterogeneous or predominantly homogeneous). Lymph nodes from the same primary tumour could differ completely from each other (Table IV, Figure 1 ). 1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 Samples (%) (Brattain et at., 1977 (Brattain et at., , 1979 (Brattain et at., , 1981 Chen et at., 1982; Dexter et at., 1979; Enblad et at., 1985; Kimball et at., 1978; Kimball & Brattain, 1980; Petersen et al., 1979a, b; .
The precise mechanisms behind antigenic heterogeneity are uncertain. Variations in the expression of various compounds during the cell cycle, unstable genotypes and/or unstable phenotypes have been suggested (Arends et at., 1984b; Edwards 1985; Fidler, 1978; McCormack, 1984; Nowell, 1976; Olsson et at., 1984) . The observation of more or less large foci of antigenically defilned cancer cells suggests that, at least in some cases, coexistence of several clones might be one of the correct explanations. Since heterogeneity was also seen in metastasis it may be suggested either that -new clones arise very frequently in this heteroploid cancer (Enblad et at., 1985; Petersen et at., 1979a, b) Because of the intratumoral antigenic heterogeneity found it is evident that an interpretation of rectal carcinomas based upon preoperative biopsies, using this panel of antibodies, would be inaccurate in many cases (Table III, Figure 1 ). This conclusion is further substantiated by the fact that in a few cases where multiple preoperative biopsies were examined, a variability between 0% and 100% positive cells were seen for certain antigens (Enblad et al., unpublished observation) . Furthermore, the heterogeneity may complicate the use of monoclonal antibodies in tumour imaging and therapy. Thus, monoclonal immunotherapy devices may be more efficient in antigenically less heterogeneous cancers. However, immunohistochemical screening may help to identify potentially the most appropriate antibodies for in vivo applications, as e.g. anti-CEA in the present study, which had a broad spectrum of reactivity both in primary tumours and metastasis.
An immunohistochemical classification based upon samples much larger than preoperative biopsies seems to be more accurate (Table III) . The staining patterns did not correlate with degree of differentiation and Dukes' stage (Table II) , which so far gives the best prediction of clinical course. However, the prognostic relevance may not be definitely assessed until the patients have been followed for longer time periods and the immunohistochemical profiles related to patient survival.
